The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CARA THERAPEUTICS INC COM 140755109 0 0 SH   SOLE   0 0 0
CHARGEPOINT HOLDINGS INC COM CL A 15961R105 81,025 4,053,257 SH   SOLE   4,053,257 0 0
LIVEXLIVE MEDIA INC COM NEW 53839L208 11,135 3,724,137 SH   SOLE   3,724,137 0 0
MERSANA THERAPEUTICS INC COM 59045L106 7,511 796,458 SH   SOLE   796,458 0 0
NGM BIOPHARMACEUTICALS INC COM 62921N105 79,175 3,766,666 SH   SOLE   3,766,666 0 0
ON24 INC COM 68339B104 0 0 SH   SOLE   0 0 0
SENSEONICS HLDGS INC COM 81727U105 541 159,601 SH   SOLE   159,601 0 0